Drug Trial Radar · NCT00003994
Combination Chemotherapy With or Without Amifostine in Treating Young Patients With Liver Cancer
Last checked: Nov 20, 2026Latest source record: Jun 14, 2013 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
277
Actual
Start
Mar 1999
Primary completion
Oct 2007
Sponsor
- Lead sponsor
- Children's Oncology GroupResearch network
- Sponsor type
- Research network
- Collaborators
- National Cancer Institute (NCI)
- First posted
- Jan 27, 2003
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, up to 21 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Drugs used in chemotherapy work in different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. Chemoprotective drugs such as amifostine may protect normal cells from the side effects of chemotherapy. It is not yet known which chemotherapy regimen is most effective for children and young adults with liver cancer. This randomized phase III trial is studying giving combination chemotherapy together with amifostine to see how well it works compared to combination chemotherapy alone in treating patients with liver cancer.
Conditions
- Childhood Hepatoblastoma
- Recurrent Childhood Liver Cancer
- Stage I Childhood Liver Cancer
Interventions
therapeutic conventional surgeryProcedure
Undergo surgical resection
cisplatinDrug
Given IV
vincristine sulfateDrug
Given IV
fluorouracilDrug
Given IV
amifostine trihydrateDrug
Given IV
carboplatinDrug
Given IV
Primary outcomes
What the sponsor says the trial is designed to measure.
- Event-free survival (EFS) ratesTime frame: Up to 8 years
- Toxicity rates assessed using National Cancer Institute (NCI) Common Toxicity Criteria (CTC)Time frame: Up to 8 years
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Children's Oncology Group
Arcadia, California
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.